Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.158 | An Open-Label Multicenter Extension Study to Determine Long Term Safety and Efficacy of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures | Dr. Kwan Patrick |
| 2011.028 | An open-label multi-center study of erlotinib (Tarceva®) as first line therapy until and beyond RECIST progression in NSCLC patients who harbor EGFR mutations | Prof. MOK Tony Shu Kam |
| 2011.562 | An Open-Label Long-term Safety Extension Trial for Subjects with Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC) | Professor Tam Lai-Shan |
| 2005.300 | An Open-Label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80mg + Hydrochlorothiazide 25mg tablets Alone or in Combination with Other Antihypertensive Medications in Patients with Hypertension | Prof. Kong Pik Shan Alice |
| 2002.411 | An Open-Label Extension Trial to Assess The Safety of Galantamine HBr in the Treatment of Vascular Dementia Revised : cre-2002.216-t, cre-2002.124-t | Prof. Wong Ka Sing Lawrence |
| 2021.567 | An open-label extension study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in study participants with persistent or chronic primary immune thrombocytopenia (ITP) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2019.481 | AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF REGN3918 IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Dr. WONG Raymond Siu Ming |
| 2021.535 | An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Marstacimab Prophylaxis in Severe (Coagulation Factor Activity <1%) Hemophilia A Participants With or Without Inhibitors or Moderately Severe to Severe Hemophilia B Participants (Coagulation Factor Activity ≤2%) With or Without Inhibitors |
Dr. LEUNG Wing Kwan 梁永堃 |
| 2011.599 | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn | Dr Ng Siew Chien |
| 2003.293 | An Open-Label Extension Study to Assess the Safety and Tolerability of a 25mg Dose of SCH 420814 as Monotherapy in Subjects with Early Parkinson | Prof. Wong Ka Sing Lawrence |
| 2008.382 | An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures | Dr Kwan Patrick |
| 2006.367 | An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects with ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer | Dr. Ho Wing Ming |
| 2007.371 | An Open-Label Clinical Trial to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (PEGASYS_) Plus Entecavir (Baraclude) combination Therapy in HBeAg Positive Chronic Hepatitis B (CHB) Patients | Prof. Sung JY Joseph |
| 2013.430 | AN OPEN-LABEL BOSUTINIB TREATMENT EXTENSION STUDY FOR SUBJECTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO HAVE PREVIOUSLY PARTICIPATED IN BOSUTINIB STUDIES B1871006 OR B1871008 | Dr. WONG Raymond Siu Ming |
| 2004.371 | An Open-Label 7-Day Study to Determine the Influence of CYP2C19 Genotype on the Pharmacokinetics of RO2052349 in Patients with Type 2 Diabetes Mellitus in the Asia-Pacific Region | Prof. Brian Tomlinson |
| 2018.362 | An open uncontrolled trial of Imagery Rescripting for Depression |
Ms. LEE Sze Wai 李思慧 |
| 2005.415 | An Open Label, Randomized, Parallel Group, Multicentre, Phase III Study to Assess Efficacy, Safety and Tolerability of Gefitinib (IRESSA | Prof. Mok SK Tony |
| 2003.190 | An Open Label, Randomized, Multicenter, Phase II Study to Determine Hemoglobin Dose Response, Safety and Pharmacokinetic Profile of Ro 50-3821 Given Subcutaneously Once Weekly or Once Every 3 Weeks to Anemic Patients with Stage IIIB or IV Non-Small Cell Lung Carcinoma Receiving Antineoplastic Therapy | Prof. Mok S.K. Tony |
| 2007.038 | An Open Label, Randomized, Multi-Center, Parallel Group Study to Demonstrate Treatment of Anemia Using Intravenous Injections of RO0503821 in Patients with Chronic Kidney Disease Who are on Dialysis | Dr. Li KT Philip |
| 2010.600 | An Open Label, Randomized, Cross-Over Study to Investigate the Single Dose Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg) Compared to Lamotrigine Compressed/Standard Tablets (25mg) in Chinese Healthy Male Subjects. | Professor Tomlinson Brian |
| 2014.409 | An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Prof. CHAN Anthony Tak Cheung |
| 2022.174 | AN OPEN LABEL, RANDOMISED, PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MTL-CEBPA ADMINISTERED IN COMBINATION WITH SORAFENIB OR SORAFENIB ALONE, IN TKI NAÏVE PARTICIPANTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS B OR HEPATITIS C VIRUS (OUTREACH2) |
Prof. CHAN Stephen Lam 陳林 |
| 2013.117 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Dr. Hui Aric Josun |
| 2013.115 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Prof Chan Lik Yuen Henry |
| 2011.616 | An Open Label, Pharmacogenetic study of Bisoprolol Treatment in Patients with Uncontrolled Essential Hypertension | Professor Tomlinson Brian |
| 2010.547 | An Open Label, Non-Interventional, Observtional Study Following Implantation of the enVista Intraocular Lens | Prof Lam Shun Chiu Dennis |
| 2001.437 | An Open Label, Non-comparative Study to Assess the Efficacy and Safety of Oral Gemifloxacin 320mg, Once Daily for Seven Days, for the Treatment of Community-acquired Pneumonia of Suspected Pneumococcal Origin in Countries with a High Prevalence of Drug-resistant Respiratory Pathogens | Prof. Cheung Wai Lun Allen |
| 2013.460 | An open label, multicentre, single-arm trial to assess the safety of afatinib for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR mutation(s) | Dr. LAM Kwok Chi |
| 2021.582 | An open label, first-in-human study of BAY 2927088 in participants with advanced non-small cell lung cancer (NSCLC) harboring an EGFR and/or HER2 mutation | Dr. LOONG Herbert Ho Fung |
| 2005.279 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Indenix-Sponsored Telbivudine Studies | Prof. Chan Lik Yuen Henry |
| 2005.109 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies | Dr. Leung WY Nancy |
| 2007.036 | An Open Label Tolerability and Safety Study of KRX-101 (Sulodexide Gelcaps) for the Treatment of Type 2 Diabetic Nephropathic Patients with Persistent Microalbuminuria in Australia, New Zealand, and Hong Kong | Prof. Tong Chun Yip Peter |
| 2006.249 | An Open Label Study to Assess the Efficacy of Losartan/HCTZ Combination Therapy in Patients with Essential Hypertension Who Were Inadequately Controlled on Current Antihypertensive Monotherapy | Prof. Tong Chun Yip Peter |
| 2014.668 | An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection | Prof. CHAN Henry Lik Yuen |
| 2011.048 | An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy | Dr Ho Wing Ming |
| 2006.230 | An Open Label International Multi-Center Phase 2 Activity and Safety Study of SU011248 in Patients with Unresectable Hepatocellular Carcinoma | YEO Winnie |
| 2006.205 | An Open Label International Multi-Center Phase 2 Activity and Safety Study of SU011248 in Patients with Advanced / Metastatic Gastric Cancer Progressing or Recurring After One Prior Chemotherapy | Prof. Yeo Winnie |
| 2004.030 | An One-Year Audit of Patients Attending A Multidisciplinary Out-patient Pain Centre | YEUNG Cheryl |
| 2014.319 | An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK3277510A and GSK3277509A administered in adults 18 to 60 years of age. | Prof. HUI David Shu Cheong |
| 2019.260 | AN OBSERVER BLIND, RANDOMIZED STUDY WITH AN OPEN LABEL PART TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUS ADMINISTRATION OF RO7191863 WITH MULTIPLE DOSES AND DIFFERENT REGIMENS IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B INFECTION |
Prof. WONG Grace Lai Hung 陳力元 |
| 2020.512 | An observational, prospective study using forced oscillation to diagnose and monitor pulmonary complications in patients with Systemic Sclerosis |
Dr. YIP Wing Ho 葉永豪 |
| 2011.283 | An observational, multination, multi-centre, prospective, open-label study to assess effectiveness, safety and tolerability in patients wit arterial hypertension receiving amlodipine / valsartan in a real-world setting | Dr LAM Chun-wai, Willis |
| 2012.519 | An observational, multi-center, prospective, open-label study to assess the real-life treatment pattern for Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong and its adherence to GOLD guideline | Dr CHAN Hok Sum, Christopher |
| 2012.499 | An observational, multi-center, prospective, open-label study to assess the real-life treatment pattern for Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong and its adherence to GOLD guideline | DR Choo Kah Lin |
| 2012.491 | An observational, multi-center, prospective, open-label study to assess the real-life treatment pattern for Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong and its adherence to GOLD guideline | Prof Hui Shu Cheong David |
| 2016.487 | An observational study to examine the effectiveness of oral methycobalamin in correcting vitamin B12 deficiency in geriatric outpatients |
Dr. KWOK Timothy 郭志銳 |
| 2015.709 | An Observational Study to Evaluate Integrative Medicine in Managing Fatigue and Cognitive Deficits Associated with Multiple Sclerosis and Neuromyelitis Optica |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2008.359 | An Observational Study to Assess Back Pain in Patients with Severe Ostoporosis Treated with Teriparatide versus Antiresorptives | LEUNG Ping Chung |
| 2018.651 | An observational study on the changes in oral and gut microbiota following cancer therapy |
Prof. CHAN Paul K.S. 陳基湘 |
| 2008.333 | An Observational Study on Prevalence of Hydronephrosis in Patients with Pelvic Organ Prolapse | Dr Hui Shuk Yi Annie |
Page 199 of 254.